Examining muscle relaxant dose, risk of encephalopathy in patients with CKD

(JAMA Network) Whether a higher or lower dose of the muscle relaxant baclofen was associated with 30-day risk of hospitalization with encephalopathy (defined as a main diagnosis of delirium, disorientation, transient alteration of awareness, transient ischemic attack or an unclear diagnosis of dementia) among newly prescribed patients with chronic kidney disease was the focus of this observational study with nearly 16,000 older adults.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news